Product Program year 2021 Source: CMS Open Payments

Liposorber

Device Lipid Apheresis

PDI 14993478010110

Open in the dashboard

General payments

$290,273

41 payments

Research payments

$136,314

14 payments

Through program year 2021, $290,273 in general payments and $136,314 in research payments were reported against Liposorber (Lipid Apheresis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $290,273 41
2021 Research $136,314 14

Breakdown

Who paid General payments · program year 2021
  1. Kaneka Pharma America LLC $290,273 41 payments
Top recipients General payments · program year 2021
  1. Patrick Moriarty Clinical Pharmacology · Kansas City, KS $55,000 19% · 1 payment
  2. Stephan Babirak Endocrinology, Diabetes & Metabolism · Scarborough, ME $32,142 11% · 1 payment
  3. Seth Baum Cardiovascular Disease · Boca Raton, FL $22,095 8% · 1 payment
  4. John Diaz Family Medicine · Naples, FL $20,552 7% · 1 payment
  5. Eliot Brinton Endocrinology, Diabetes & Metabolism · Salt Lake City, UT $18,375 6% · 1 payment

The top 5 of 41 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Clinical Pharmacology $55,000 30% · 1 practitioner
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $52,017 28% · 3 practitioners
  3. Cardiovascular Disease Internal Medicine $32,607 18% · 6 practitioners
  4. Family Medicine $20,552 11% · 1 practitioner
  5. Anatomic Pathology & Clinical Pathology Pathology $11,369 6% · 1 practitioner

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Kansas $55,000 19% · 1 recipient
  2. Florida $43,320 15% · 3 recipients
  3. Maine $32,142 11% · 1 recipient
  4. California $23,696 8% · 6 recipients
  5. Utah $18,375 6% · 1 recipient

The top 5 of 28 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

41 general · 14 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record